CNBC's Meg Tirrell reports on Eli Lilly beating on earnings as the stock dips almost 4% and Biogen pops on an earnings beat.
CNBC's Meg Tirrell reports the highlights of the pharmaceutical company's quarterly earnings.
David Ricks, Eli Lilly CEO, talks about the company's quarterly results which beat on the top and bottom line, driven largely by the introduction of new drugs in the marketplace. Also Ricks weighs in on the Democrats' "Better Deal" proposal.
The full interview with Eli Lilly CEO David Ricks.